Core Viewpoint - The Ministry of Industry and Information Technology (MIIT) aims to achieve over 100 breakthroughs in key measurement technologies, develop more than 100 sets of high-end measuring instruments, and cultivate over 50 quality enterprises in the instrument and meter sector by 2027, supporting the construction of a manufacturing powerhouse [2][4]. Group 1: Overall Requirements - The initiative is guided by Xi Jinping's thoughts and aims to enhance the innovation capability of manufacturing measurement, focusing on precision measurement and establishing a robust calibration service system [5]. - By 2027, significant progress is expected in manufacturing measurement, including breakthroughs in over 100 key calibration technologies and the establishment of a resilient supply chain [5]. Group 2: Strengthening Effective Supply of Measurement - Key common measurement technologies will be targeted for breakthroughs, particularly in emerging fields like quantum technology and artificial intelligence [7]. - Development of high-end measuring instruments will be accelerated, focusing on precision, integration, and intelligence [8]. - The development of standard substances will be prioritized across various key industries, enhancing quality and traceability [9]. Group 3: Deepening Measurement Application Empowerment - Innovative measurement service models will be supported, providing integrated solutions for enterprises to enhance precision measurement [13]. - Strengthening measurement verification services is essential, ensuring compliance with legal standards for measurement instruments [14]. - Establishing high-level measurement technical service institutions will be prioritized to meet manufacturing demands [15]. Group 4: Promoting Measurement Innovation and Upgrading - Advanced measurement management practices will be encouraged, integrating measurement management into enterprise operations [17]. - The development of high-end measurement capabilities will be promoted, enhancing service quality and responsiveness to precision measurement needs [18]. - The application of intelligent technologies in measurement will be emphasized, promoting digital transformation in the sector [19]. Group 5: Strengthening Support Measures - Organizational implementation will be enhanced, ensuring effective execution of existing policies supporting manufacturing measurement [21]. - Increased resource investment will be encouraged, supporting financing for measurement institutions and promoting capital investment in measurement technology [22]. - International cooperation will be fostered, enhancing global integration in measurement technology development [24].

Core Viewpoint - The Ministry of Industry and Information Technology and the National Development and Reform Commission have issued a notice to cultivate pilot-scale biomanufacturing platforms, aiming to establish over 20 platforms and serve more than 200 enterprises by 2027, with the goal of incubating over 400 products [1][2][3]. Group 1: Cultivation Areas - The initiative focuses on addressing the shortcomings and pain points in the pilot-scale phase of biomanufacturing, targeting key product areas such as food and additives, biopharmaceuticals, cosmetics, chemicals, energy, and enzyme preparations [5]. - Emphasis will be placed on developing pilot platforms for new raw materials in biomanufacturing, particularly lignocellulosic materials and one-carbon compounds (e.g., carbon monoxide, methanol) [5]. - The program will also support the establishment of pilot platforms for plant chassis cells, which utilize genetically modified plant cells (such as tobacco, rice, and Taxus cells) to fill gaps in emerging fields [5].

Core Viewpoint - The article highlights various high-paying job opportunities in the scientific instrument sector, emphasizing the demand for skilled sales and technical professionals in this industry [2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24]. Job Opportunities - Shanghai Kezhe Biochemical Technology Co., Ltd. is seeking an Amino Acid Analyzer Sales Manager with a salary range of 16k-35k per month [2]. - Guoyi Quantum is looking for a Client Manager in Jinan, offering a salary of 10k-18k per month [3]. - Beijing Leshi Lianchuang Technology Co., Ltd. is hiring a Sales Engineer in Shenyang with a salary of 10k-13k per month [4]. - Shanghai Yanzheng Experimental Instrument Co., Ltd. is offering a Sales Engineer position in Guangzhou with a salary range of 8k-16k per month [5]. - North Division Ruili is recruiting a Sales Manager in Chongqing with a salary of 8k-10k per month [6]. - Beijing Chengda Instrument Co., Ltd. is looking for a Sales Engineer in Beijing with a salary range of 6k-12k per month [8]. - Liaoning Jiahua International Trade Co., Ltd. is hiring an Instrument Sales Engineer in Shenyang with a salary of 5k-10k per month [9]. - Beijing Dongxi Analysis Instrument Co., Ltd. is offering a Sales Engineer position in Xining with a negotiable salary [10]. - Res tek is seeking a Chromatography Consumables Sales Engineer in Suzhou with a salary range of 7k-14k per month [11]. - Shanghai Beiyin Biotechnology Co., Ltd. is looking for an International Trade Sales position in Suzhou with a salary of 8k-15k per month [12]. Technical and Support Roles - Shanghai offers a position for an Application Engineer (Online Analysis Instruments) with a negotiable salary [14]. - Carl Zeiss (Shanghai) Management Co., Ltd. is hiring a Technical Support Engineer with a salary range of 12k-20k per month [16]. - Changzhou Pannuo Instrument Co., Ltd. is looking for a Service Engineer in multiple regions with a salary of 6k-10k per month [17]. - Qingdao Shenghan Chromatography Technology Co., Ltd. is seeking an Application R&D Expert with a salary range of 12k-25k per month [18]. - Beijing Rongchuang Intelligent Instrument Co., Ltd. is hiring a Biological Microscope Technical Service Engineer in Beijing with a salary of 6k-10k per month [19]. Additional Roles - Dalian Huayang Analysis Instrument Co., Ltd. is offering a Service Assistant position in Beijing with a negotiable salary [20]. - Zhuhai Truth Optical Instrument Co., Ltd. is looking for a Regional Manager with a salary range of 8k-20k per month [21]. - Zhejiang Fuli Analysis Instrument Co., Ltd. is hiring a Technical Engineer in Xi'an with a salary of 5k-6k per month [22]. - Yuanwei Max Bio is seeking a Technical Support Engineer in Nanjing with a salary range of 7k-15k per month [23]. - Shenzhen Zhongtu Instrument Co., Ltd. is looking for a Scanning Electron Microscope Product Manager with a salary range of 10k-25k per month [24].

Group 1 - The core viewpoint of the article is that Thermo Fisher Scientific is selling part of its diagnostic business for approximately $4 billion (about 287.24 billion RMB) to optimize its asset portfolio and divest from underperforming business segments [1][4]. - The company has engaged financial advisors to seek private equity investors for the sale of its diagnostic business, which includes the microbiology department that produces infectious disease testing equipment [4]. - There is no guarantee that the asset sale will be completed, and Thermo Fisher Scientific may ultimately decide to retain the asset [4]. Group 2 - Earlier in February, the company completed the acquisition of Solventum's purification and filtration business for $4.1 billion in cash [4].

Core Viewpoint - Central to the article is the announcement of multiple government procurement intentions by Central South University, detailing 28 items of laboratory equipment with a total budget of 128 million yuan, scheduled for procurement between April and December 2025 [1][2]. Summary by Relevant Sections Procurement Overview - Central South University has outlined procurement intentions for various scientific instruments, with a total budget of 128 million yuan [1][2]. - The procurement includes advanced equipment such as ultra-high temperature synchronous thermal analyzers, multi-field coupled low-field nuclear magnetic resonance imaging instruments, X-ray fluorescence spectrometers, and quantum efficiency testing instruments [2]. Specific Equipment Details - **Ultra-high Temperature Synchronous Thermal Analyzer**: - Quantity: 1 unit - Purpose: To study thermal changes and mass changes of materials under high-temperature conditions [4]. - **Multi-field Coupled Low-field Nuclear Magnetic Resonance Imaging Instrument**: - Quantity: 1 unit - Purpose: To analyze the microstructure and fluid information of porous media samples under various conditions [4][10]. - **X-ray Fluorescence Spectrometer**: - Quantity: 1 unit - Purpose: For qualitative and quantitative analysis of materials, covering elements from Be to U [5][9]. - **Quantum Efficiency Testing Instrument**: - Quantity: 1 unit - Purpose: To measure the quantum efficiency of new solar cells and other materials [5]. Additional Equipment and Applications - **Scanning Electron Microscope**: - Quantity: 1 unit - Features: High-resolution imaging capabilities and various operational modes [6]. - **Laser Intelligent Processing Platform**: - Purpose: To support advanced manufacturing education and practical training for students [6]. - **Three-dimensional X-ray Imaging System**: - Purpose: To enhance scanning capabilities for larger samples [9]. Budget and Timeline - The total budget for the procurement is set at 128 million yuan, with the procurement process expected to take place from April to December 2025 [1][2].

Core Viewpoint - In 2024, domestic listed instrument companies are experiencing a transformative year amid complex international environments and rapid advancements in technologies such as artificial intelligence, IoT, and big data, leading to both opportunities and challenges for the industry [2]. Summary by Sections Financial Performance Overview - Among 45 listed instrument companies, 38 reported positive net profits while 7 reported negative net profits, with the highest profit growth at 455.96% and the lowest at -760.56% [1][5]. - The leading company, Mindray Medical, achieved a net profit of 11.668 billion, a slight increase of 0.74% from the previous year, indicating its strong market position and resilience [5][6]. Companies with Increased Net Profits - Companies such as Sunny Optical (+145.52%), Focused Photonics (+164.11%), and SanDe Technology (+166.55%) reported over 100% growth in net profits, showcasing successful strategies in technology innovation and market expansion [6][9]. - Notable transformations from losses to profits were observed in companies like Nanhua Instruments and Yirui Biology, indicating potential pathways for other small and medium enterprises in the industry [6][12]. Companies with Decreased Net Profits - Companies like Meiya Optoelectronics and SuShi Testing faced profit declines due to intensified market competition and rising costs, reflecting the challenges within the industry [12][14]. - The impact of policy adjustments and technological challenges was evident in companies such as Hanwei Technology and Kehua Bio, which experienced significant profit drops [12][14]. Profit Distribution Analysis - The distribution of net profits among the 45 companies shows that 35.56% experienced profit growth, while 57.78% faced declines, highlighting a significant disparity in financial performance across the sector [14][15]. - The majority of companies reported low profit margins, with only a few achieving high profitability, indicating a concentrated market where a small number of firms dominate the profits [7][14]. Future Outlook - The industry is at a new historical starting point, facing both challenges and unprecedented development opportunities, particularly in high-end manufacturing and intelligent manufacturing sectors [16]. - Strengthening independent innovation capabilities and enhancing product quality will be crucial for driving the industry towards high-quality development [16].

Core Viewpoint - The article discusses the naming conventions of analytical instruments as per the standard GB/T12519-2021, emphasizing the importance of adhering to established naming principles to avoid confusion in the industry [1][2]. Group 1: Naming Principles - The naming of analytical instruments is guided by specific principles that consider the measurement method and the object being measured [2]. - Instruments that measure a single substance (excluding gases) and assign values are typically referred to as "meters," such as pH meters and salinity meters [2]. - Instruments designed to measure gases are generally called "analyzers," for example, carbon monoxide analyzers and carbon dioxide analyzers [2]. - Instruments that analyze images to study the morphology of substances are referred to as "microscopes," such as transmission electron microscopes and scanning electron microscopes [2]. - Systems that encompass sample processing, analytical instruments, data management, and auxiliary facilities are usually called "systems," like air quality detection systems and water quality detection systems [2]. - Other analytical instruments not fitting the above categories are generally referred to as "instruments" [2]. - Safety alarm instruments that only provide sound or light warnings are typically called "alarm devices," while those with other display methods are referred to as "explosion detectors" or "detectors" [2].

Core Viewpoint - Phoenix Optical plans to invest 85 million USD (approximately 60 million RMB) to establish a wholly-owned subsidiary in Vietnam, marking a significant step in its overseas strategic layout to meet the diversified supply chain needs of international clients and further expand its global market presence [2][3]. Investment Overview - The new company, tentatively named "Phoenix Optical (Vietnam) Co., Ltd.", will have a registered capital of 85 million USD and will be located in Vinh City, Nghe An Province, Vietnam. Its main business will include the production, processing, sales, and import-export of optoelectronic products. The project is expected to be completed and put into operation by 2026, with investment funds allocated for factory renovation, equipment procurement, and working capital [4]. Strategic Significance - This investment is a key move for Phoenix Optical to extend its industrial chain and enhance its international competitiveness. The establishment of the production base in Vietnam will help the company better serve overseas clients, respond to the global supply chain diversification trend, optimize cost structure, and improve market responsiveness. The company emphasizes that its current financial condition is stable, and this investment will not adversely affect its main business or cash flow [5]. Industry Impact - Phoenix Optical's move to establish a base in Vietnam reflects the accelerating trend of Chinese optoelectronic companies "going global." With the restructuring of global supply chains, Vietnam is becoming a hotspot for manufacturing investment due to its labor cost advantages and favorable policies. This initiative may serve as a reference for peers in the industry and promote the internationalization process within the sector [6].

Core Viewpoint - The beauty industry is currently facing a significant controversy regarding the actual content of recombinant collagen, with a focus on the lack of standardized testing methods and criteria, which has led to a trust gap between brands and consumers [2]. Group 1: Industry Controversy - A beauty blogger reported that the recombinant collagen content in a popular product was only 0.0177%, significantly below the national standard of 0.1%, and failed to detect key amino acids like glycine [2]. - The controversy centers not on the technical routes or raw material sources, but on the choice of testing methods and the absence of unified standards, which has hindered the compliant development of the medical beauty industry [2]. Group 2: Regulatory Developments - Since 2022, the National Medical Products Administration (NMPA) has been releasing industry standards for recombinant collagen, including YY/T 1849-2022 and YY/T 1888-2023, to address the heterogeneity of recombinant collagen products [3]. - The introduction of mass spectrometry as a "gold standard" for quality control in recombinant collagen is expected to replace traditional methods that are susceptible to interference from other proteins [3]. Group 3: New Standards Implementation - On August 1, 2022, the NMPA implemented YY/T 1805.3-2022, which provides a high-specificity method for detecting collagen content using LC-MS/MS, addressing the limitations of traditional methods [4]. - A new standard, YY/T 1954-2025, for peptide fingerprint analysis of recombinant collagen is set to be implemented on March 1, 2026, which will enhance quality control and regulatory capabilities in the medical beauty industry [8]. Group 4: Industry Support and Collaboration - The Instrument Information Network is actively monitoring developments in cosmetic testing and promoting collaboration in the field, emphasizing the importance of advancements in testing technology and equipment [13].

导读： 在所有测试任务中，Biomni 展现出显著的性能优势：相较于基础大语言模型提升 402.3%！目前研究团队在https://biomni.stanford.edu/开放免费注册 和使用。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 2025 年 6 月 2 日，斯坦福大学 黄柯鑫、Serena Zhang、王瀚宸、屈元昊、陆荧洲 等研究人员领衔的团队，联合 Genentech、Arc Ins titute、加州大学旧金山分校及普林斯顿大学等多个顶尖研究机构，发布了一款通用生物医学 AI 智能体—— Biomni 。该智能体能够自主 完成横跨遗传学、基因组学、微生物学、药理学和临床医学等多个生物医学分支领域的复杂研究任务。 Biomni 通过将分散的科研资源整合为可操作的智能体行为单元，不仅破解了传统研究流程的碎片化瓶颈，更可能催生跨学科、高通量的自主 化科学发现引擎。 该研究以：Biomni : A General-Purpose Biomedical AI Agent 为题，发表在了预印本平台 bioRx i v。 更重要的是 ...